SEC Form SC 13D/A filed by Neuronetics Inc. (Amendment)

8/18/23 4:02:32 PM ET

$STIM

Medical/Dental Instruments

Health Care

Get the next $STIM alert in real time by email

SC 13D/A 1 ccllc-STIM-13d-081723.htm SCHEDULE 13D/A

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 3)

Neuronetics, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

64131A105

(CUSIP Number)

J. Carlo Cannell

Cannell Capital LLC

245 Meriwether Circle

Alta, WY 83414

(307) 733-2284

(Name, Address and Telephone Number of Person

to Receive Notices and Communications)

August 17, 2023

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

(Continued on following pages)

(Page 1 of 8 Pages)

______________________

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a current valid OMB control number.

CUSIP No. 64131A105

Page 2 of 8 Pages

1	NAME OF REPORTING PERSON Cannell Capital LLC I.R.S. Identification Nos. of above persons (entities only) 94-3366999
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
3	SEC USE ONLY
4	SOURCE OF FUNDS (see instructions) WC/OO
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) ☐ or 2(e) ☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER* 2,440,536
		8	SHARED VOTING POWER 0
		9	SOLE DISPOSITIVE POWER* 2,440,536
		10	SHARED DISPOSITIVE POWER 0
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,440,536
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐ (see instructions)
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 8.45%*
14	TYPE OF REPORTING PERSON IA

* Based on information set forth on the 10-Q of Neuronetics, Inc., (the “Company”, “Registrant”, or “STIM”) as filed with the Securities and Exchange Commission on August 8, 2023, there were 28,873,388 shares of Common Stock par value $0.01 per share (the “Shares”), of the Company issued and outstanding as of August 2, 2023.

As of August 17, 2023 (the “Reporting Date”), Tristan Partners, L.P. (“Tristan”), the Tristan Offshore Fund Ltd. (“Tristan Offshore”), Tonga Partners, L.P. (“Tonga”) and sundry separately-managed accounts (“Cannell SMAs”) (collectively, the “Investment Vehicles”), over which J. Carlo Cannell has investment discretion held in the aggregate 2,440,536 Shares.

CUSIP No. 64131A105

Page 3 of 8 Pages

1	NAMES OF REPORTING PERSONS I.R.S. Identification Nos. of above persons (entities only) J. Carlo Cannell
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐
3	SEC USE ONLY
4	SOURCE OF FUNDS (see instructions) WC/OO
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) ☐ or 2(e) ☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER* 2,440,536
		8	SHARED VOTING POWER 0
		9	SOLE DISPOSITIVE POWER* 2,440,536
		10	SHARED DISPOSITIVE POWER 0
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,440,536
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐ (see instructions)
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11 8.45%*
14	TYPE OF REPORTING PERSON IN

* Based on information set forth on the Form 10-Q of Company as filed with the Securities and Exchange Commission on August 8, 2023, there were 28,873,388 shares of Common Stock par value $0.01 per Share of Company issued and outstanding as of August 2, 2023.

As of Reporting Date the Investment Vehicles held in the aggregate 2,440,536 Shares.

CUSIP No. 64131A105

Page 4 of 8 Pages

Cannell Capital LLC acts as the investment adviser to Tonga, Tristan, and Tristan Offshore and the investment advisor to sundry separately-managed accounts. Mr. J. Carlo Cannell is the sole managing member of Cannell Capital LLC. The Reporting Person possesses the sole power to vote and to direct the disposition of the Shares held by the Investment Vehicles.


Item 1. Security and Issuer
		The title of the class of equity securities to which this Schedule 13D relates is the Common Stock par value $0.01 per share of Neuronetics, Inc., a Delaware corporation. The address of the principal executive offices of the Company is 3222 Phoenixville Pike, Malvern, PA 19355.
Item 2. Identity and Background
	a)	The name of the Reporting Person is J. Carlo Cannell (the “Reporting Person”). The Reporting Person is the sole managing member of Cannell Capital LLC and investment adviser to the following entities: Tristan Partners, L.P. Tristan Offshore Fund, Ltd. Tonga Partners, L.P. Separately-Managed Accounts Set forth in the attached Annex "A" and incorporated herein by reference is a listing of the directors, general partners, managing members and controlling persons of the Reporting Person and the Investment Vehicles (collectively, the “Covered Persons”), and sets forth the principal occupation, citizenship and principal place of business of each Covered Person.
	b)	The principal business address of the Reporting Person is: 245 Meriwether Circle Alta, WY 83414
	c)	The principal business of the Reporting Person is the performance of investment management and advisory services. The principal business of the Investment Vehicles is investment in securities.
	d)	Neither the Reporting Person, nor to the best of its knowledge, any of the Investment Vehicles, has, in the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
	e)	Neither the Reporting Person, nor to the best of its knowledge, any of the Investment Vehicles, has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgement, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws.
	f)	The place of organization of the Reporting Person is as follows: The citizenship of each Covered Person is set forth on the attached Annex A and incorporated herein by reference. Mr. J. Carlo Cannell is the Managing Member of Cannell Capital LLC, a Wyoming limited liability company.
Item 3. Source and Amount of Funds or Other Consideration
		The securities to which this statement relates were acquired by the Reporting Person using the working capital of each Investment Vehicle as follows: Tristan Partners, L.P.: $10,446,535 Tristan Offshore Fund, Ltd.: $4,475,436 Tonga Partners, L.P.: $304,596 Separately-Managed Accounts: $1,769,716 The Investment Vehicles have invested an aggregate amount of approximately $16,996,283 in the Shares.

CUSIP No. 64131A105

Page 5 of 8 Pages


Item 4. Purpose of Transaction
	Cannell Capital LLC (“CC”), on behalf of the Investment Vehicles, identified the Company as an entity satisfying each of the Investment Vehicle's investment criteria. The Investment Vehicles acquired these shares in the ordinary course of business and not with the intent to change or influence control of the Company. The Investment Vehicles continue to hold the Shares as a long-term investment. Mr. Cannell makes this filing to disclose recent transactions in the Shares. Other than the matters discussed above, CC has no present plans or proposals to engage in any of the actions specified in Items 4(a) through 4(j) to the Schedule 13D general instructions with regards to the Company.
Item 5. Interest in Securities of the Issuer
	Based on information set forth in the Company's Form 10-Q as filed with the Securities and Exchange Commission on August 8, 2023, there were 28,873,388 Common Shares issued and outstanding as of August 2, 2023. (a) As of the Reporting Date, for the purposes of Reg. Section 240.13d-3, Cannell Capital LLC may be deemed to beneficially own 2,440,536 Shares, or approximately 8.45% of the Shares deemed issued and outstanding as of the Reporting Date. (b) Cannell Capital LLC possesses the sole power to vote and to direct the disposition of the Shares held by the Investment Vehicles. (c) The following table details the transactions during the sixty days on or prior to the Reporting Date in Shares, or securities convertible into, exercisable for or exchangeable for Shares, by Cannell Capital LLC or any other person or entity controlled by him or any person or entity for which he possesses voting or investment control over the securities thereof (each of which was effected in an ordinary brokerage transaction by Cannell Capital LLC on behalf of the Investment Vehicles) and which were not previously disclosed in a prior Amendment.
		Entity	Date	Quantity	Price Per Share	Form Of Transaction

		Cannell SMAs	06/28/2023	5,545	2.10	Sell
		Tonga	07/25/2023	12,541	2.00	Sell
		Cannell SMAs	07/25/2023	4.632	2.00	Sell
		Tonga	08/08/2023	47,467	1.87	Sell
		Cannell SMAs	08/08/2023	17,533	1.87	Sell
		Cannell SMAs	08/08/2023	40,000	1.89	Buy
		Cannell SMAs	08/09/2023	49,000	1.87	Buy
		Tonga	08/09/2023	25,559	1.85	Sell
		Cannell SMAs	08/09/2023	9,441	1.85	Sell
		Tonga	08/10/2023	18,256	1.79	Sell
		Cannell SMAs	08/10/2023	6,744	1.79	Sell
		Tonga	08/11/2023	12,573	1.76	Sell
		Cannell SMAs	08/11/2023	4,644	1.76	Sell
		Tonga	08/14/2023	184,512	1.65	Sell
		Cannell SMAs	08/14/2023	68,155	1.65	Sell
		Tonga	08/16/2023	3,760	1.85	Sell
		Cannell SMAs	08/16/2023	1,389	1.85	Sell

CUSIP No. 846517100

Page 6 of 8 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: August 17, 2023

Cannell Capital LLC

By: /s/ J. Carlo Cannell

Name: J. Carlo Cannell

Title: Managing Member

CUSIP No. 64131A105

Page 7 of 8 Pages

Annex "A"

MANAGERS AND GENERAL PARTNERS OF THE REPORTING PERSON AND THE INVESTMENT VEHICLES

The following sets forth the name, principal occupation, citizenship or jurisdiction of organization and principal place of business of the directors, general partners, managing members or controlling persons of the Reporting Person and the Investment Vehicles (the “Covered Persons”) indicated below:

J. Carlo Cannell
Name: Title or Relationship with Reporting Person: Principal Occupation or Employment: Citizenship or Jurisdiction of Organization: Principal Place of Business:	J. Carlo Cannell Managing Member Investment Management Wyoming, United States (1)
Cannell Capital LLC
Name: Title or Relationship with Reporting Person: Principal Occupation or Employment: Citizenship or Jurisdiction of Organization: Principal Place of Business:	J. Carlo Cannell Managing Member Investment Management Wyoming, United States (1)
Tristan Partners, L.P.
Name: Title or Relationship with Reporting Person: Principal Occupation or Employment: Citizenship or Jurisdiction of Organization: Principal Place of Business:	Cannell Capital LLC Investment Adviser and General Partner Investment Management Wyoming, United States (1)
Tristan Offshore Fund, Ltd.
Name: Title or Relationship with Reporting Person: Principal Occupation or Employment: Citizenship or Jurisdiction of Organization: Principal Place of Business:	Cannell Capital LLC Investment Adviser Investment Management Cayman Islands (2)
Tonga Partners, L.P.
Name: Title or Relationship with Reporting Person: Principal Occupation or Employment: Citizenship or Jurisdiction of Organization: Principal Place of Business:	Cannell Capital LLC Investment Adviser and General Partner Investment Management Wyoming, United States (1)

CUSIP No. 64131A105

Page 8 of 8 Pages

Annex "B"

Agreement Regarding the Joint Filing of Schedule 13D

Each of them is individually eligible to use the Schedule 13D to which this Exhibit is attached, and such Schedule 13D is filed on behalf each of them;

Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

Dated: August 17, 2023

By: /s/ J. Carlo Cannell

Name: J. Carlo Cannell

Cannell Capital LLC

By: /s/ J. Carlo Cannell

Name: J. Carlo Cannell

Title: Managing Member

Get the next $STIM alert in real time by email

Date

Price Target

Rating

Analyst

8/13/2024

Outperform → Mkt Perform

William Blair

10/14/2021

$18.00 → $12.00

Market Outperform

JMP Securities

10/13/2021

Outperform → Mkt Perform

William Blair

10/13/2021

Buy → Neutral

BTIG

Item 1. Security and Issuer

The title of the class of equity securities to which this Schedule 13D relates is the Common Stock par value $0.01 per share of Neuronetics, Inc., a Delaware corporation.
The address of the principal executive offices of the Company is 3222 Phoenixville Pike, Malvern, PA 19355.

Item 2. Identity and Background

The name of the Reporting Person is J. Carlo Cannell (the “Reporting Person”).

The Reporting Person is the sole managing member of Cannell Capital LLC and investment adviser to the following entities:

Tristan Partners, L.P.

Tristan Offshore Fund, Ltd.

Tonga Partners, L.P.

Separately-Managed Accounts

Set forth in the attached Annex "A" and incorporated herein by reference is a listing of the directors, general partners, managing members and controlling persons of the Reporting Person and the Investment Vehicles (collectively, the “Covered Persons”), and sets forth the principal occupation, citizenship and principal place of business of each Covered Person.

The principal business address of the Reporting Person is:

245 Meriwether Circle

Alta, WY 83414

The principal business of the Reporting Person is the performance of investment management and advisory services. The principal business of the Investment Vehicles is investment in securities.

Neither the Reporting Person, nor to the best of its knowledge, any of the Investment Vehicles, has, in the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

Neither the Reporting Person, nor to the best of its knowledge, any of the Investment Vehicles, has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgement, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws.

The place of organization of the Reporting Person is as follows:

The citizenship of each Covered Person is set forth on the attached Annex A and incorporated herein by reference.

Mr. J. Carlo Cannell is the Managing Member of Cannell Capital LLC, a Wyoming limited liability company.

Item 3. Source and Amount of Funds or Other Consideration

The securities to which this statement relates were acquired by the Reporting Person using the working capital of each Investment Vehicle as follows:

Tristan Partners, L.P.: $10,446,535

Tristan Offshore Fund, Ltd.: $4,475,436

Tonga Partners, L.P.: $304,596

Separately-Managed Accounts: $1,769,716

The Investment Vehicles have invested an aggregate amount of approximately $16,996,283 in the Shares.

Item 4. Purpose of Transaction

Cannell Capital LLC (“CC”), on behalf of the Investment Vehicles, identified the Company as an entity satisfying each of the Investment Vehicle's investment criteria. The Investment Vehicles acquired these shares in the ordinary course of business and not with the intent to change or influence control of the Company. The Investment Vehicles continue to hold the Shares as a long-term investment.

Mr. Cannell makes this filing to disclose recent transactions in the Shares. Other than the matters discussed above, CC has no present plans or proposals to engage in any of the actions specified in Items 4(a) through 4(j) to the Schedule 13D general instructions with regards to the Company.

Item 5. Interest in Securities of the Issuer

Based on information set forth in the Company's Form 10-Q as filed with the Securities and Exchange Commission on August 8, 2023, there were 28,873,388 Common Shares issued and outstanding as of August 2, 2023.

(a) As of the Reporting Date, for the purposes of Reg. Section 240.13d-3, Cannell Capital LLC may be deemed to beneficially own 2,440,536 Shares, or approximately 8.45% of the Shares deemed issued and outstanding as of the Reporting Date.

(b) Cannell Capital LLC possesses the sole power to vote and to direct the disposition of the Shares held by the Investment Vehicles.

(c) The following table details the transactions during the sixty days on or prior to the Reporting Date in Shares, or securities convertible into, exercisable for or exchangeable for Shares, by Cannell Capital LLC or any other person or entity controlled by him or any person or entity for which he possesses voting or investment control over the securities thereof (each of which was effected in an ordinary brokerage transaction by Cannell Capital LLC on behalf of the Investment Vehicles) and which were not previously disclosed in a prior Amendment.

Entity

Date

Quantity

Price

Per Share

Form Of

Transaction

Cannell SMAs

06/28/2023

5,545

2.10

Sell

Tonga

07/25/2023

12,541

2.00

Sell

Cannell SMAs

07/25/2023

4.632

2.00

Sell

Tonga

08/08/2023

47,467

1.87

Sell

Cannell SMAs

08/08/2023

17,533

1.87

Sell

Cannell SMAs

08/08/2023

40,000

1.89

Buy

Cannell SMAs

08/09/2023

49,000

1.87

Buy

Tonga

08/09/2023

25,559

1.85

Sell

Cannell SMAs

08/09/2023

9,441

1.85

Sell

Tonga

08/10/2023

18,256

1.79

Sell

Cannell SMAs

08/10/2023

6,744

1.79

Sell

Tonga

08/11/2023

12,573

1.76

Sell

Cannell SMAs

08/11/2023

4,644

1.76

Sell

Tonga

08/14/2023

184,512

1.65

Sell

Cannell SMAs

08/14/2023

68,155

1.65

Sell

Tonga

08/16/2023

3,760

1.85

Sell

Cannell SMAs

08/16/2023

1,389

1.85

Sell

Date

Price Target

Rating

Analyst

8/13/2024

Outperform → Mkt Perform

William Blair

10/14/2021

$18.00 → $12.00

Market Outperform

JMP Securities

10/13/2021

Outperform → Mkt Perform

William Blair

10/13/2021

Buy → Neutral

BTIG

SEC Form SC 13D/A filed by Neuronetics Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$STIM

SEC Form SC 13D/A filed by Neuronetics Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$STIM

$STIM
Insider Purchases

Director Cascella Robert bought $75,000 worth of shares (100,000 units at $0.75), increasing direct ownership by 28% to 453,098 units (SEC Form 4)

Director Muir Glenn P bought $20,000 worth of shares (25,000 units at $0.80), increasing direct ownership by 9% to 289,818 units (SEC Form 4)

Director Muir Glenn P bought $21,250 worth of shares (25,000 units at $0.85), increasing direct ownership by 10% to 264,818 units (SEC Form 4)

$STIM
Press Releases

Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

$STIM
Insider Trading

EVP, CFO and Treasurer Pfanstiel Steven was granted 170,212 shares, increasing direct ownership by 43% to 570,212 units (SEC Form 4)

EVP, GC, CCO and CS Macan William Andrew was granted 164,361 shares, increasing direct ownership by 31% to 691,166 units (SEC Form 4)

Director Cucuz Sasha was granted 6,410 shares, increasing direct ownership by 0.43% to 1,512,798 units (SEC Form 4)

$STIM
SEC Filings

SEC Form 8-K filed by Neuronetics Inc.

SEC Form 8-K filed by Neuronetics Inc.

SEC Form 10-Q filed by Neuronetics Inc.

$STIM
Analyst Ratings

Neuronetics downgraded by William Blair

JMP Securities reiterated coverage on Neuronetics with a new price target

Neuronetics downgraded by William Blair

$STIM
Leadership Updates

Neuronetics Appoints New Chief Financial Officer

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

Dr. Mehdi H. Shishehbor Appointed Chief Medical Officer of Inquis Medical

$STIM
Financials

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

$STIM
Large Ownership Changes

SEC Form SC 13D filed by Neuronetics Inc.

Amendment: SEC Form SC 13G/A filed by Neuronetics Inc.

Amendment: SEC Form SC 13G/A filed by Neuronetics Inc.

SEC Form SC 13D/A filed by Neuronetics Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $STIM

SEC Form SC 13D/A filed by Neuronetics Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $STIM

$STIM Insider Purchases

Director Cascella Robert bought $75,000 worth of shares (100,000 units at $0.75), increasing direct ownership by 28% to 453,098 units (SEC Form 4)

Director Muir Glenn P bought $20,000 worth of shares (25,000 units at $0.80), increasing direct ownership by 9% to 289,818 units (SEC Form 4)

Director Muir Glenn P bought $21,250 worth of shares (25,000 units at $0.85), increasing direct ownership by 10% to 264,818 units (SEC Form 4)

$STIM Press Releases

Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

$STIM Insider Trading

EVP, CFO and Treasurer Pfanstiel Steven was granted 170,212 shares, increasing direct ownership by 43% to 570,212 units (SEC Form 4)

EVP, GC, CCO and CS Macan William Andrew was granted 164,361 shares, increasing direct ownership by 31% to 691,166 units (SEC Form 4)

Director Cucuz Sasha was granted 6,410 shares, increasing direct ownership by 0.43% to 1,512,798 units (SEC Form 4)

$STIM SEC Filings

SEC Form 8-K filed by Neuronetics Inc.

SEC Form 8-K filed by Neuronetics Inc.

SEC Form 10-Q filed by Neuronetics Inc.

$STIM Analyst Ratings

Neuronetics downgraded by William Blair

JMP Securities reiterated coverage on Neuronetics with a new price target

Neuronetics downgraded by William Blair

$STIM Leadership Updates

Neuronetics Appoints New Chief Financial Officer

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

Dr. Mehdi H. Shishehbor Appointed Chief Medical Officer of Inquis Medical

$STIM Financials

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

$STIM Large Ownership Changes

SEC Form SC 13D filed by Neuronetics Inc.

Amendment: SEC Form SC 13G/A filed by Neuronetics Inc.

Amendment: SEC Form SC 13G/A filed by Neuronetics Inc.

Recent Analyst Ratings for
$STIM

Recent Analyst Ratings for
$STIM

$STIM
Insider Purchases

$STIM
Press Releases

$STIM
Insider Trading

$STIM
SEC Filings

$STIM
Analyst Ratings

$STIM
Leadership Updates

$STIM
Financials

$STIM
Large Ownership Changes